YC S23
Olio Labs
Combination therapeutics for the world's toughest diseases
About
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
Founders
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Olio Labs.
See family office activityIndustry & Focus
HealthcareDrug Discovery and Delivery